Xiaodong Yang - 29 Jul 2022 Form 3 Insider Report for Apexigen, Inc.

Role
Chief Executive Officer, Director
Signature
/s/ Francis Sarena, by power of attorney
Issuer symbol
N/A
Transactions as of
29 Jul 2022
Net transactions value
$0
Form type
3
Filing time
08 Aug 2022, 16:49:33 UTC
Next filing
11 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding APGN Common Stock 497,904 29 Jul 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding APGN Employee Stock Option (right to buy) 29 Jul 2022 Common Stock 219,950 $1.27 Direct F1
holding APGN Employee Stock Option (right to buy) 29 Jul 2022 Common Stock 20,489 $1.47 Direct F1
holding APGN Employee Stock Option (right to buy) 29 Jul 2022 Common Stock 461,015 $1.66 Direct F1
holding APGN Employee Stock Option (right to buy) 29 Jul 2022 Common Stock 35,856 $2.25 Direct F1
holding APGN Employee Stock Option (right to buy) 29 Jul 2022 Common Stock 30,734 $2.25 Direct F1
holding APGN Employee Stock Option (right to buy) 29 Jul 2022 Common Stock 295,978 $3.62 Direct F2
holding APGN Employee Stock Option (right to buy) 29 Jul 2022 Common Stock 99,373 $6.54 Direct F3
holding APGN Employee Stock Option (right to buy) 29 Jul 2022 Common Stock 12,296 $7.03 Direct F4
holding APGN Employee Stock Option (right to buy) 29 Jul 2022 Common Stock 79,906 $4.59 Direct F5
holding APGN Employee Stock Option (right to buy) 29 Jul 2022 Common Stock 38,417 $4.59 Direct F6
holding APGN Warrant (right to buy) 29 Jul 2022 Common Stock 10,000 $11.50 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option are fully vested and immediately exercisable.
F2 The shares subject to the option vest in 48 equal monthly installments beginning on June 22, 2018.
F3 The shares subject to the option vest in 48 equal monthly installments beginning on March 14, 2019.
F4 The shares subject to the option vest in 48 equal monthly installments beginning on February 1, 2020.
F5 The shares subject to the option vest in 48 equal monthly installments beginning on February 1, 2020.
F6 The shares subject to the option vest in 48 equal monthly installments beginning on February 1, 2021.
F7 The shares underlying the warrant become exercisable on August 28, 2022.

Remarks:

Exhibit 24 - Power of Attorney